Mycophenolat 1 A Pharma (Mycophenolate Mofetil)

Mycophenolate Mofetil is used to modulate immune activity in transplant and autoimmune disease pathways.

• Organ transplant rejection: helps prevent graft rejection by suppressing lymphocyte proliferation.
• Lupus nephritis: reduces renal inflammation and proteinuria in patients with systemic lupus erythematosus.
• Other autoimmune diseases (off‑label): may be employed to manage conditions such as vasculitis or dermatomyositis where immune suppression is required.

• Mycophenolate Mofetil is a selective inhibitor of inosine monophosphate dehydrogenase (IMPDH), the key enzyme in de novo guanosine nucleotide synthesis. By blocking IMPDH, the drug depletes guanosine triphosphate pools, which preferentially impairs proliferation of T and B lymphocytes that rely on this pathway, thereby attenuating the immune response.

Mycophenolate Mofetil may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Diarrhea: frequent loose stools.
• Headache: transient cranial pain.
• Infections: increased susceptibility to bacterial or viral infections.

Serious or Rare Side Effects

• Severe infections: opportunistic infections such as CMV or PCP.
• Bone marrow suppression: leukopenia, anemia, or thrombocytopenia.
• Hepatic toxicity: elevated liver enzymes or hepatitis.
• Progressive multifocal leukoencephalopathy (PML): rare demyelinating disease.

When prescribing Mycophenolate Mofetil, several precautions should be observed to ensure patient safety.

• Monitor blood counts: perform regular complete blood count to detect leukopenia or anemia.
• Assess liver function: check hepatic enzymes periodically.
• Avoid use in pregnancy: drug is contraindicated (Category X) and requires effective contraception.
• Counsel on contraception: both male and female patients should use reliable birth control methods.
• Adjust for renal impairment: dose may need reduction in patients with reduced kidney function.
• Store at below 25°C: keep in the original packaging, protect from moisture and light.

Mycophenolate Mofetil interacts with several medicines that can alter its efficacy or safety profile.

Major Interactions (Avoid)

• Live vaccines: may cause uncontrolled infection due to immunosuppression.
• Strong CYP3A4 inhibitors (e.g., azole antifungals, clarithromycin): increase mycophenolate exposure and toxicity.
• Antacids containing aluminum or magnesium: reduce oral absorption of mycophenolate.

Moderate Interactions (Monitor Closely)

• Calcineurin inhibitors (e.g., cyclosporine, tacrolimus): additive immunosuppression may increase infection risk.
• Inactivated vaccines: efficacy may be reduced; timing should be coordinated.